Next Generation Sequencing Market Report 2025-2035

The Next Generation Sequencing Market Report 2025-2035 Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Rising Disease Prevalence Creating Strong Demand for NGS

The increasing prevalence of complex diseases is another powerful driver for the NGS market. Rising cancer incidence, recurrent viral outbreaks, and the growing recognition of genetic disorders are all stimulating demand for advanced sequencing methods. NGS enables researchers and clinicians to decode genetic variations that underlie these diseases, supporting the development of targeted therapies and precision medicine approaches.

Rare diseases highlight this demand most clearly.More than 7,000 rare conditions affect over 30 million people in the United States alone, yet only a fraction of these diseases currently have approved treatments. This unmet need is encouraging biopharmaceutical companies to increase investment in clinical trials focused on rare conditions, with NGS playing a central role in identifying causative mutations and potential therapeutic pathways.

At the same time, emerging economies are experiencing shifts in their disease burden, moving from infectious diseases to more chronic and lifestyle-related conditions. This epidemiological transition is expanding the application of NGS to new areas of healthcare research. The growing variation in disease profiles worldwide reinforces the importance of sequencing technologies, both for addressing urgent public health challenges and for advancing long-term research into conditions that have historically been neglected.

What would be the Impact of US Trade Tariffs on the Global Next Generation Sequencing Market ?

Trade tariffs imposed by the United States have the potential to reshape the economics of the global next generation sequencing (NGS) industry. Instruments, reagents, and critical components such as flow cells and chips are often manufactured or sourced internationally, particularly from Asia. Tariffs on these imports increase procurement costs, making sequencing more expensive for academic institutions, clinical laboratories, and pharmaceutical firms. This risks slowing down clinical adoption at a time when affordability and accessibility are key to widespread uptake.

For suppliers, tariffs create pressure to reconfigure supply chains. While some US manufacturers may see short-term advantages, the market overall faces inefficiencies and rising operational costs as companies diversify sourcing or relocate production. Smaller sequencing service providers, who lack the financial resilience of larger players, may struggle to absorb these pressures, leading to greater market consolidation.

Globally, tariffs could accelerate regionalisation. Asia and Europe may push to strengthen domestic manufacturing capacity and reduce dependence on US suppliers, potentially fragmenting what has traditionally been a highly collaborative international market. In the longer term, the disruption of global supply flows and restricted access to affordable components could slow innovation cycles, with negative consequences for research and precision medicine.

What Questions Should You Ask before Buying a Market Research Report?

• How is the next generation sequencing market evolving?
• What is driving and restraining the next generation sequencing market?
• How will each next generation sequencing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
• How will the market shares for each Next Generation Sequencing submarket develop from 2025 to 2035?
• What will be the main driver for the overall market from 2025 to 2035?
• Will leading next generation sequencing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
• Who are the leading players and what are their prospects over the forecast period?
• What are the next generation sequencing projects for these leading companies?
• How will the industry evolve during the period between 2025 and 2035? What are the implications of
  next generation sequencing projects taking place now and over the next 10 years?


• Is there a greater need for product commercialisation to further scale the next generation sequencing market?
• Where is the next generation sequencing market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Next Generation Sequencing market today, and over the next 10 years:

• Our 336-page report provides 126 tables and 219 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Type

• Consumables
• Bioinformatics
• Sequencing Services
• Pre-sequencing Services
• Instruments

Workflow

• Library Preparation
• Sequencing
• Data Analysis

Application

• Oncology
• Reproductive Health
• Genetic and Rare Diseases
• Consumer Genomics
• Agrigenomics & Forensics
• Others

End-users

• Hospitals and Clinics
• Academic and Research Institutes
• Pharmaceutical and Biotech Companies
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles for 13 major companies in the Next Generation Sequencing Market, 2025 to 2035, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

• 10X Genomics
• Agilent Technologies, Inc.
• BGI Group
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific
• F. Hoffman-La Roche Ltd
• Illumina, Inc.
• Oxford Nanopore Technologies plc
• PacBio
• PerkinElmer
• QIAGEN
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

Overall world revenue for Next Generation Sequencing Market, 2025 to 2035 in terms of value the market will surpass US$11,530 million in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Next Generation Sequencing Market, 2025 to 2035 report help you?

In summary, our 330+ page report provides you with the following knowledge:

• Revenue forecasts to 2035 for Next Generation Sequencing Market 2025 to 2035, with forecasts for type, workflow, application, and end-users, each forecast at a global and regional level – discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2035 for five regional and 20 key national markets – See forecasts for the Next Generation Sequencing Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 13 of the major companies involved in the Next Generation Sequencing Market, 2025 to 2035.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment. Show more